New Data Suggest GSK and Sanofi’s Covid Vaccine Could Pose a Challenge to Pfizer and Moderna
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- MRNA
- RGVAX
- PFE
- GSK
- SNY
- SNYNF
Sanofi and GSK's joint Covid-19 vaccine has finally produced data that could challenge the dominance of the Pfizer and Moderna vaccines.